A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2020-02-13
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety of the study drug known as LY3039478
in combination with other anticancer agents in participants with advanced or metastatic solid
tumors.